Abstract:
We achieve a successful paradigm of generating SARS virus-like particles (VLPs) in large quantity from mammalian cell culture. We demonstrate that the VLPs as vaccine antigens are highly immunogenic to animals. In addition, the VLPs can be coated on microplates as diagnostic assays to detect host antibodies against SARS virus. While SARS virus is highly infectious, the VLPs are biologically safe and useful for vaccine development. The invention allow us to transfer a few viral genes into Vero E6 cells within a short time to generate VLPs of other animal viruses in reasonable high yields.
Fields of Application:
1.SARS Vaccine development 2.SARS diagnosis 3.Animal virus-like particles generation.
Advantages when compared to the existing technologies:
1.Biologically safe, as compared to killed or attenuated virus. 2.Expression and packaging in mammalian cells. 3.Substantially higher yields than baculovirus expression system. 4.Fast procedure to generate VLPs of a new virus.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
IP Status:US pending TW I340166
